Lithuanian Cervical Cancer Implementation Guide
0.0.1 - ci-build
Lithuanian Cervical Cancer Implementation Guide
0.0.1 - ci-build
Lithuanian Cervical Cancer Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-cervical/ and changes regularly. See the Directory of published versions
Dabartiniam puslapiui nėra vertimo puslapio, todėl jis pateiktas numatytąja kalba
Turinys:
Šiame puslapyje pateikiamas FHIR artefaktų, apibrėžtų šiame diegimo vadove, sąrašas.
Jie apibrėžia formas, kurias naudoja sistemos, atitinkančios šį įgyvendinimo vadovą, duomenims rinkti ar pateikti galutiniams vartotojams.
| Questionnaire: Cervical Colposcopy ESPBI Form |
ESPBI form for capturing colposcopy examination data in the Lithuanian cervical cancer screening programme. |
| Questionnaire: Cervical Cytology and HPV ESPBI Form |
ESPBI form for cervical cancer screening: HPV testing and cytological examination. Based on ADP Table 7.1 (cervical cancer prevention program cytology and HPV kit). |
| Questionnaire: Cervical Histopathological Examination – ESPBI (definition) |
ESPBI form for cervical histopathological examination based on ADP document Table 7.2. |
| Questionnaire: Cervical Pathological Diagnosis ESPBI Form |
ESPBI form for structured coding of cervical pathological diagnoses using VLK, ICD-10-AM, ICD-O, and SNOMED CT classification systems. |
Jie apibrėžia FHIR resursų apribojimus sistemoms, atitinkančioms šį įgyvendinimo vadovą.
| Cervical Cancer Screening Report (LT Cervical) |
Overall cervical cancer diagnostic report covering the entire screening and diagnostic pathway. Wraps a CervicalCompositionLtCervical and aggregates structured results including HPV testing, cytology, colposcopy findings, and histopathology conclusions. |
| Cervical Composition (LT Cervical) |
Cervical cancer screening episode composition extending the base imaging composition. Links all diagnostic reports (HPV, cytology, colposcopy, histopathology) produced during the cervical cancer screening and diagnostic pathway into a single clinical document. |
| Condition: Cervical Cancer (LT Cervical) |
Cervical cancer condition with pathological TNM staging (pT, pN, pR) and morphology classification. Follows the pattern established by ProstateConditionLtLab. |
| Cytology Conclusion |
Final cytological diagnostic conclusion of cervical cytology examination in the Lithuanian cervical cancer screening and diagnostic pathway (ADP). |
| DiagnosticReport: Cervical Cytology (Pap Test) |
Laboratory diagnostic report representing cervical cytology examination in the Lithuanian cervical cancer screening pathway (ADP). |
| DiagnosticReport: Cervical Histopathology (LT Cervical) |
Histopathological examination report for cervical tissue obtained from biopsy or excisional procedures. Based on DiagnosticReportLt with pathology-specific constraints for cervical cancer. |
| DiagnosticReport: Colposcopy |
Diagnostic report summarizing findings and procedures performed during colposcopy in the Lithuanian cervical cancer screening pathway. |
| DiagnosticReport: HPV Test |
Laboratory diagnostic report representing HPV DNA testing in the Lithuanian cervical cancer screening pathway (ADP). |
| HPV Test Result |
HPV DNA test result with optional component for specifying detected high-risk genotypes. |
| Observation: Cervical Histopathology Conclusion (LT Cervical) |
Histopathological diagnostic conclusion for cervical tissue examination. Records the morphological diagnosis, histological grade, lymphovascular invasion (pLVI), and surgical margin status. |
| Observation: Clinical History |
A panel of pre-analytic clinical observations. |
| Observation: Colposcopy Findings |
Clinical findings recorded during colposcopy, including suitability for assessment and Swede score. |
| Observation: History of Colposcopy |
Indicates whether the patient has a history of colposcopy examination, when detailed procedure data is not available. |
| Procedure: Cervical Biopsy during Colposcopy |
Biopsy or excisional procedures performed during colposcopy as part of the Lithuanian cervical cancer screening pathway. |
| Procedure: Colposcopy |
Colposcopy procedure performed as part of the Lithuanian cervical cancer screening and diagnostic pathway (ADP). |
Jie apibrėžia kodų rinkinius, naudojamus sistemų, atitinkančių šį įgyvendinimo vadovą.
| Cervical Biopsy Quadrant |
Anatomical quadrants of the uterine cervix used to localize biopsy sites. |
| Cervical Biopsy Site (LT Cervical) |
Anatomical localization of cervical biopsy sampling sites during colposcopy. |
| Cervical Cytology Test Types |
Types of cytological examinations ordered in the cervical cancer prevention program. Used in ServiceRequest.code and DiagnosticReport.code to classify the specific test type. |
| Cervical Histological Grade |
Histological differentiation grades for cervical cancer, based on AJCC grading system. |
| Cervical Histopathology Diagnosis |
Histopathological diagnostic conclusions for cervical tissue examination, aligned with WHO Classification of Female Genital Tumours (2020). |
| Cervical Microflora |
Microflora types observed during cervical cytological examination. |
| Cervical Pathogen |
Pathogens identified during cervical cytological examination. |
| Cervical Sample Collection Site (LT Cervical) |
Anatomical locations for sample collection. |
| Cervical Surgical Margins |
Status of surgical margins in cervical excision specimens. |
| Cervical TNM pR Stage |
Pathological residual tumor (pR) classification for cervical cancer, AJCC 8th edition. |
| Cervical TNM pT Stage [RETIRED] |
RETIRED — Use CervicalTumorStageTLtLab from the Lab IG instead, which includes full pTX–pT4 staging. This ValueSet only covered pTX–pT1b2. |
| Cervix - Cytology Conclusion (LT Cervical) |
Cytological diagnostic conclusions and specimen adequacy categories used in the Lithuanian cervical cancer screening and diagnostic pathway (ADP), aligned with Bethesda terminology. |
| Cervix - Cytology Preparation Method (LT Cervical) |
Specimen preparation methods for cervical cytology in the Lithuanian cervical cancer screening pathway (conventional smear vs liquid-based cytology). |
| Cervix - HPV Genotypes (LT Cervical) |
High-risk Human Papillomavirus (HPV) genotypes and groups detected in cervical cancer screening. |
| Cervix - HPV Test Result (LT Cervical) |
Overall result codes for HPV DNA testing. |
| Colposcopy Adequacy (LT Cervical) |
Suitability of colposcopy examination for clinical assessment in the Lithuanian cervical cancer screening pathway. Uses specimen adequacy findings from the Lab IG. |
| Colposcopy Swede Score Risk Category (LT Cervical) |
Risk categories derived from Swede score during colposcopy examination. |
| Colposcopy-related Procedures (LT Cervical) |
Procedures that may be performed during colposcopy in the Lithuanian cervical cancer screening pathway. |
| HPV Risk Groups ValueSet (LT Cervical) |
ValueSet containing the ADP-specific risk buckets. |
| HPV Vaccination Status (LT Cervical) |
Status of HPV vaccination. |
| Yes / No / Unknown (SNOMED CT) (LT Cervical) |
Codes used to represent clinical presence or absence. |
Jie apibrėžia naujas kodų sistemas, naudojamas sistemų, atitinkančių šį įgyvendinimo vadovą.
| Cervix Scoring Instruments (LT Cervical) [RETIRED] |
Local codes for cervical cancer screening scoring instruments. |
| HPV Risk Groups CodeSystem (LT Cervical) |
Specific HPV risk groupings |
Tai yra pavyzdiniai egzemplioriai, kurie parodo, kaip gali atrodyti duomenys, sukurti ir sunaudoti sistemų, atitinkančių šį įgyvendinimo vadovą.
| Cervix HPV Specimen example |
Example cervix HPV specimen used in the LT Cervical IG |
| Colposcopy Diagnostic Report example |
Sample colposcopy diagnostic report used in the LT Cervical IG |
| Colposcopy Finding Observation example |
Example colposcopy finding observation used in the LT Cervical IG |
| Colposcopy History Observation example |
Example colposcopy history observation used in the LT Cervical IG |
| Colposcopy Procedure example |
Example colposcopy procedure used in the LT Cervical IG |
| Composition: Cervical Cancer Screening Episode (example) |
Example of a cervical cancer screening episode composition linking HPV, cytology, and colposcopy diagnostic reports. |
| Condition: Cervical Cancer pT1a1 Stage (example) |
Example of a cervical cancer condition with pathological TNM staging and ICD-O morphology. |
| Cytology Conclusion Observation example |
Example cytology conclusion observation used in the LT Cervical IG |
| Cytology Diagnostic Report example |
Sample cytology diagnostic report used in the LT Cervical IG |
| DiagnosticReport: Cervical Cancer Screening Report (example) |
Example of a cervical cancer screening report linking HPV, cytology, and colposcopy results. |
| DiagnosticReport: Cervical Histopathology Report (example) |
Example of a cervical histopathology report documenting HSIL/CIN2 diagnosis from cone biopsy. |
| DiagnosticReport: HPV DNA Test (example) |
HPV laboratory diagnostic report for cervical cancer screening. |
| HPV Result Group Observation example |
Example HPV result group observation used in the LT Cervical IG |
| HPV Result Observation example |
Example HPV result observation used in the LT Cervical IG |
| Observation: Cervical Histopathology Conclusion – HSIL/CIN2 (example) |
Example of a cervical histopathology conclusion showing HSIL/CIN2 with G2 grade, clear margins, and no lymphovascular invasion. |
| Observation: Cervical Tumor Measurement (example) |
Example of a cervical lesion measurement showing dimensions obtained from histopathological examination. |
| Observation: Clinical History - Complex (example) |
A clinical history illustrating the usage of >1 year comparator for chemotherapy, DateTime for previous conization, and Yes/No/Unknown codeable concepts. |
| Observation: Clinical History - Routine (example) |
A standard history for a young patient with no prior treatments. |
| Observation: HPV Complex - Type 16 AND Medium Risk Group (example) |
A scenario where the patient is coinfected. The lab identified HPV 16 specifically, but also found a positive signal for the Medium Risk pool. |
| Organization: Vilniaus miesto ligoninė (example) |
Example of a healthcare organization |
| Patient: Female (example) |
An example Patient conforming to the Lithuanian Base Profile. |
| Practitioner: Dr. Petras Kazlauskas (example) |
An example Practitioner conforming to the Lithuanian Base Profile. |
| PractitionerRole: Dr. Petras Kazlauskas – Gynecologist (example) |
An example PractitionerRole linking the practitioner to the organization. |
| QuestionnaireResponse: Cervical Colposcopy ESPBI (example) |
Example response for the colposcopy ESPBI form: adequate colposcopy with Swede score 3 (low risk), punch biopsy from left superior quadrant. |
| QuestionnaireResponse: Cervical Cytology and HPV ESPBI Form (example) |
Completed ESPBI form for routine cervical screening: HPV 16 detected (highest risk), LSIL on cytology, p16/Ki-67 positive. |
| QuestionnaireResponse: Cervical Histopathology – HSIL/CIN2, Cone Biopsy (example) |
Completed ESPBI cervical histopathological examination response: cone biopsy from left superior quadrant with HSIL/CIN2 diagnosis, G2 grade, clear margins, no pLVI, pTis staging. |
| QuestionnaireResponse: Cervical Pathological Diagnosis ESPBI (example) |
Example response for the pathological diagnosis ESPBI form: HSIL/CIN2 with VLK 2238, ICD-10 D06.9, ICD-O 8077/2, SNOMED 400049009. |
| Specimen: Cervical Cone Biopsy (example) |
Example of a cervical tissue specimen obtained via cone biopsy for histopathological examination. |